Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hematologic Neoplasms 1Colorectal Neoplasms 1Burkitt Lymphoma 1

Interventions

Filgrastim 11Cyclophosphamide 11Rituximab 10fludarabine phosphate 9Mycophenolic Acid 9Cyclosporine 9Antilymphocyte Serum 9Radiotherapy 7Peripheral Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Cord Blood Stem Cell Transplantation 6Polymerase Chain Reaction 5Methotrexate 5Flow Cytometry 5Busulfan 5Tacrolimus 4Methylprednisolone 4Etoposide 4Amplified Fragment Length Polymorphism Analysis 4tanespimycin 3sargramostim 3Melphalan 3Lenalidomide 3Granulocyte Colony-Stimulating Factor 3Gene Expression Profiling 3Bortezomib 3thymoglobulin 2plerixafor 2aldesleukin 2Stem Cell Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, Large-Cell, Immunoblastic × Antibodies, Bispecific × Clear all
NCT00014560 2018-05-03

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Dartmouth-Hitchcock Medical Center

Phase 1 Terminated
3 enrolled 3 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡